| Protocol | Title |
|---|---|
| 90202 | A Randomized, Double Blind, Placebo-Controlled Phase III Study of
Early versus Standard Zoledronic Acid to Prevent Skeletal Related
Events in Men with Prostate Cancer Metastatic to Bone
Activation Date: 09-feb-2004 |
| C90203 | A Randomized Phase III Study of Neoadjuvant Docetaxel and Androgen
Deprivation Prior to Radical Prostatectomy versus Immediate Radical
Prostatectomy in Patients with High-Risk, Clinically Localized
Prostate Cancer
Activation Date: 22-dec-2006 |
| CALGB90601 | A Randomized Phase III Study of Gemcitabine, Cisplatin, Bevacizumab
or Gemcitabine, Cisplatin, and Placebo in Patients with Advanced
Transitional Cell Carcinoma
Activation Date: 07-aug-2009 |
| E1808 | A Randomized Phase II Trial of Sunitinib/Gemcitabine or Sunitinib in
Advanced Renal Cell Carcinoma with Sarcomatoid Features.
Activation Date: 17-jun-2010 |
| E1809 | Randomized Phase II trial of Docetaxel with or without PSA-TRICOM
vaccine in patients with castrate-resistant metastatic prostate
cancer.
Activation Date: 09-aug-2010 |
| E2804 | The BEST Trial: A Randomized Phase II Study of VEGF, RAF kinase and
mTOR Combination Targeted Therapy (CTT) with Bevacizumab, Sorafenib
and Temsirolimus in Advanced Renal Cell Carcinoma
Activation Date: 14-sep-2007 |
| E3805 | CHAARTED: ChemoHormonal Therapy versus Androgen Ablation Randomized
Trial for Extensive Disease in Prostate Cancer
Activation Date: 28-jul-2006 |
| E4805 | A Randomized Phase II Study to Determine the Effect of 2 Different
Doses of AVE0005 (VEGF Trap) in Patients with Metastatic Renal Cell
Carcinoma
Activation Date: 21-dec-2007 ECOG Participants(requires Adobe Acrobat) |
| NCIC-PR.11 | A Phase III Study of Active Surveillance Therapy Against Radical
Treatment in Patients Diagnosed with Favorable Risk Prostate Cancer
(START)
Activation Date: 06-may-2010 |
| R0524 | A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab
with Daily Irradiation or Paclitaxel Alone with Daily Irradiation
Following Transurethral Surgery for Non-Cystectomy Candidates with
Muscle-Invasive Bladder Cancer
Activation Date: 09-jan-2007 |
| RTOG 0534 | A Phase III Trial Of Short Term Androgen Deprivation With Pelvic
Lymph Node Or Prostate Bed Only Radiotherapy (SPORT) In Prostate
Cancer Patients With A Rising PSA After Radical Prostatectomy
Activation Date: 21-nov-2007 |
All contents copyright © 1998 Eastern Cooperative Oncology Group.
All rights reserved.
Revised: 09/09/10